IperionX: Titan Definitive Feasibility Study (DFS) Presentation

Building a U.S. supply chain for heavy rare earths, titanium, zirconium and hafnium, delivering a U.S. critical mineral-to-metals platform for defense, aerospace, nuclear, semiconductors, robotics and advanced manufacturing supply chains

SOUTH BOSTON, Va., June 10, 2026 (GLOBE NEWSWIRE) --  IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to provide a link to the Titan Critical Mineral Project Definitive Feasibility Study (DFS) presentation.

Link: DFS Presentation

Figure 1: IperionX DFS presentation

About IperionX

IperionX is a leading American titanium metal and critical materials company – using patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at lower energy, cost and carbon emissions.

Our Titan critical minerals project is the largest JORC-compliant mineral resource of titanium, rare earth and zircon minerals sands in the United States.

IperionX’s titanium metal and critical minerals are essential for advanced U.S. industries including space, aerospace, defense, consumer electronics, automotive and additive manufacturing.

Contacts

Anastasios (Taso) Arima, Founder and CEO
Toby Symonds, President
Dominic Allen, Chief Commercial Officer

Investors: [email protected]
Media: [email protected]

+1 980 237 8900
www.iperionx.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a99d8ffe-78fd-4dfa-8cfa-aff10fa16c28

A PDF accompanying this announcement is available at http://ml.globenewswire.com/Resource/Download/2f946720-8ad3-4d4a-a39a-71fa474242ed

You May Also Be Interested In

• Photys Therapeutics and Polymed Biopharmaceuticals Announce the Initiation of a Phase I Clinical Trial of PHT-776/HPB-143, an Oral IRAK4 PROTAC Degrader
• The Rise of the Brown Bag Economy: As America Turns 250, a New Ramsey Solutions Study Reveals a Nation of Intentional Spenders
• Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight